Wingyl may be available in the countries listed below.
Ingredient matches for Wingyl
Metronidazole
Metronidazole is reported as an ingredient of Wingyl in the following countries:
- Myanmar
International Drug Name Search
Friday, October 28, 2016
Diflam
Diflam may be available in the countries listed below.
Ingredient matches for Diflam
Diclofenac
Diclofenac is reported as an ingredient of Diflam in the following countries:
- Indonesia
International Drug Name Search
Heptodine
Heptodine may be available in the countries listed below.
Ingredient matches for Heptodine
Lamivudine
Lamivudine is reported as an ingredient of Heptodine in the following countries:
- Argentina
International Drug Name Search
Vinorelbine PCH
Vinorelbine PCH may be available in the countries listed below.
Ingredient matches for Vinorelbine PCH
Vinorelbine
Vinorelbine tartrate (a derivative of Vinorelbine) is reported as an ingredient of Vinorelbine PCH in the following countries:
- Netherlands
International Drug Name Search
Hyzaar
Hyzaar is a brand name of hydrochlorothiazide/losartan, approved by the FDA in the following formulation(s):
HYZAAR (hydrochlorothiazide; losartan potassium - tablet; oral)
Manufacturer: MERCK
Approval date: April 28, 1995
Strength(s): 12.5MG;50MG [AB]
Manufacturer: MERCK
Approval date: November 10, 1998
Strength(s): 25MG;100MG [RLD][AB]
Manufacturer: MERCK
Approval date: October 20, 2005
Strength(s): 12.5MG;100MG [AB]
Has a generic version of Hyzaar been approved?
Yes. The following products are equivalent to Hyzaar:
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (hydrochlorothiazide; losartan potassium tablet; oral)
Manufacturer: APOTEX
Approval date: August 11, 2010
Strength(s): 12.5MG;100MG [AB]
Manufacturer: APOTEX
Approval date: October 6, 2010
Strength(s): 12.5MG;50MG [AB], 25MG;100MG [AB]
Manufacturer: AUROBINDO PHARMA
Approval date: January 6, 2010
Strength(s): 25MG;100MG [AB]
Manufacturer: AUROBINDO PHARMA
Approval date: October 6, 2010
Strength(s): 12.5MG;100MG [AB], 12.5MG;50MG [AB]
Manufacturer: LUPIN LTD
Approval date: May 21, 2010
Strength(s): 12.5MG;100MG [AB]
Manufacturer: LUPIN LTD
Approval date: October 6, 2010
Strength(s): 12.5MG;50MG [AB], 25MG;100MG [AB]
Manufacturer: MYLAN
Approval date: April 6, 2010
Strength(s): 12.5MG;100MG [AB]
Manufacturer: MYLAN
Approval date: October 6, 2010
Strength(s): 12.5MG;50MG [AB], 25MG;100MG [AB]
Manufacturer: ROXANE
Approval date: April 6, 2010
Strength(s): 12.5MG;100MG [AB]
Manufacturer: ROXANE
Approval date: October 6, 2010
Strength(s): 12.5MG;50MG [AB], 25MG;100MG [AB]
Manufacturer: SANDOZ
Approval date: August 19, 2010
Strength(s): 12.5MG;100MG [AB]
Manufacturer: SANDOZ
Approval date: October 6, 2010
Strength(s): 12.5MG;50MG [AB], 25MG;100MG [AB]
Manufacturer: TEVA PHARMS
Approval date: April 6, 2010
Strength(s): 12.5MG;100MG [AB], 12.5MG;50MG [AB], 25MG;100MG [AB]
Manufacturer: TORRENT PHARMS
Approval date: April 6, 2010
Strength(s): 12.5MG;100MG [AB]
Manufacturer: TORRENT PHARMS
Approval date: October 6, 2010
Strength(s): 12.5MG;50MG [AB], 25MG;100MG [AB]
Manufacturer: WATSON LABS
Approval date: January 12, 2011
Strength(s): 12.5MG;100MG [AB], 12.5MG;50MG [AB], 25MG;100MG [AB]
Manufacturer: ZYDUS PHARMS USA INC
Approval date: October 6, 2010
Strength(s): 12.5MG;50MG [AB], 25MG;100MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Hyzaar. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Hyzaar.
See also...
- Hyzaar Consumer Information (Drugs.com)
- Hyzaar Consumer Information (Wolters Kluwer)
- Hyzaar Consumer Information (Cerner Multum)
- Hyzaar Advanced Consumer Information (Micromedex)
- Losartan/Hydrochlorothiazide Consumer Information (Wolters Kluwer)
- Hydrochlorothiazide and losartan Consumer Information (Cerner Multum)
- Losartan and hydrochlorothiazide Advanced Consumer Information (Micromedex)
Thursday, October 27, 2016
Dolni-K
Dolni-K may be available in the countries listed below.
Ingredient matches for Dolni-K
Potassium Nitrate
Potassium Nitrate is reported as an ingredient of Dolni-K in the following countries:
- Colombia
International Drug Name Search
Sedermyl
Sedermyl may be available in the countries listed below.
Ingredient matches for Sedermyl
Isothipendyl
Isothipendyl hydrochloride (a derivative of Isothipendyl) is reported as an ingredient of Sedermyl in the following countries:
- France
International Drug Name Search
Firmagon
Firmagon is a brand name of degarelix, approved by the FDA in the following formulation(s):
FIRMAGON (degarelix acetate - powder; subcutaneous)
Manufacturer: FERRING
Approval date: December 24, 2008
Strength(s): EQ 120MG BASE/VIAL [RLD], EQ 80MG BASE/VIAL
Has a generic version of Firmagon been approved?
No. There is currently no therapeutically equivalent version of Firmagon available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Firmagon. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
GnRH antagonists
Patent 5,925,730
Issued: July 20, 1999
Inventor(s): Semple; Graeme & Jiang; Guangcheng
Assignee(s): Ferring BV
Peptides are provided which have improved duration of GnRH antagonistic properties. These antagonists may be used to regulate fertility and to treat steroid-dependent tumors and for other short-term and long-term treatment indications. These antagonists have a derivative of aminoPhe or its equivalent in the 5- and/or 6-positions. This derivative contains a carbamoyl group or a heterocycle including a urea in its side chain. Particularly effective decapeptides, which continue to exhibit very substantial suppression of LH secretion at 96 hours following injection, have the formulae: Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-4Aph(hydroorotyl)-D-4Aph(acetyl)-Leu-Lys(isopr opyl)-Pro-D-Ala-NH.sub.2, and Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-4Aph(hydroorotyl)-D-4Amf(Q.sub.2)-Leu-Lys(isop ropyl)-Pro-D-Ala-NH.sub.2, wherein Q.sub.2 is Cbm or MeCbm.Patent expiration dates:
- April 11, 2017✓✓✓
- April 11, 2017
Related Exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
- Exclusivity expiration dates:
- December 24, 2013 - NEW CHEMICAL ENTITY
See also...
- Firmagon Consumer Information (Drugs.com)
- Firmagon Consumer Information (Cerner Multum)
- Degarelix Consumer Information (Drugs.com)
- Degarelix Acetate Consumer Information (Wolters Kluwer)
- Degarelix Consumer Information (Cerner Multum)
- Degarelix Subcutaneous Advanced Consumer Information (Micromedex)
Wednesday, October 26, 2016
Serlife
Serlife may be available in the countries listed below.
Ingredient matches for Serlife
Sertraline
Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Serlife in the following countries:
- South Africa
International Drug Name Search
Viadur
In the US, Viadur (leuprolide systemic) is a member of the following drug classes: gonadotropin releasing hormones, hormones/antineoplastics and is used to treat Endometriosis, Hirsutism, Precocious Puberty, Prostate Cancer and Uterine Fibroids.
US matches:
- Viadur Implant
- Viadur
Ingredient matches for Viadur
Leuprorelin
Leuprorelin acetate (a derivative of Leuprorelin) is reported as an ingredient of Viadur in the following countries:
- United States
International Drug Name Search
Luvox CR
See also: Generic Luvox
Luvox CR is a brand name of fluvoxamine, approved by the FDA in the following formulation(s):
LUVOX CR (fluvoxamine maleate - capsule, extended release; oral)
Manufacturer: JAZZ
Approval date: February 28, 2008
Strength(s): 100MG, 150MG [RLD]
Has a generic version of Luvox CR been approved?
No. There is currently no therapeutically equivalent version of Luvox CR available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Luvox CR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
Patent 7,465,462
Issued: December 16, 2008
Inventor(s): Jeary; Theresa Ann & Morrissey; Catherine Ann & Stark; Paul
Assignee(s): Elan Pharma International Limited
A multiparticulate controlled release selective serotonin reuptate inhibitor (SSRI) formulation for oral administration is provided. The formulation includes particles of an SSRI or a pharmaceutically acceptable salt thereof, which are coated with a rate-controlling polymer that allows controlled release of the SSRI over a period of not less than about 12 hours after oral administration. The rate controlling polymer includes a film-forming water-insoluble polymer, or a mixture of a film-forming water-insoluble polymer and a film-forming water-soluble polymer.Patent expiration dates:
- May 10, 2020✓✓
- May 10, 2020
Related Exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
- Exclusivity expiration dates:
- February 28, 2011 - NEW DOSAGE FORM
See also...
- Luvox CR Extended-Release Capsules Consumer Information (Wolters Kluwer)
- Luvox CR Consumer Information (Cerner Multum)
- Luvox CR Advanced Consumer Information (Micromedex)
- Fluvoxamine Consumer Information (Wolters Kluwer)
- Fluvoxamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
- Fluvoxamine Consumer Information (Cerner Multum)
- Fluvoxamine Advanced Consumer Information (Micromedex)
- Fluvoxamine Maleate AHFS DI Monographs (ASHP)
Visanne
Visanne may be available in the countries listed below.
Ingredient matches for Visanne
Dienogest
Dienogest is reported as an ingredient of Visanne in the following countries:
- Germany
International Drug Name Search
Dolga
Dolga may be available in the countries listed below.
Ingredient matches for Dolga
Tramadol
Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Dolga in the following countries:
- Dominican Republic
International Drug Name Search
Voltaren
In the US, Voltaren (diclofenac systemic) is a member of the drug class nonsteroidal anti-inflammatory agents and is used to treat Ankylosing Spondylitis, Aseptic Necrosis, Back Pain, Frozen Shoulder, Muscle Pain, Osteoarthritis, Pain, Period Pain, Rheumatoid Arthritis and Sciatica.
US matches:
- Voltaren
- Voltaren Gel
- Voltaren Drops
- Voltaren Enteric-Coated Tablets
- Voltaren XR Extended-Release Tablets
- Voltaren Ophthalmic
- Voltaren Topical
- Voltaren-XR
- Voltaren XR
Ingredient matches for Voltaren
Diclofenac
Diclofenac is reported as an ingredient of Voltaren in the following countries:
- Bosnia & Herzegowina
- Colombia
- Ghana
- Guyana
- Kenya
- Libya
- Nigeria
- Slovenia
- Sudan
- Tanzania
- Zimbabwe
Diclofenac diethylamine (a derivative of Diclofenac) is reported as an ingredient of Voltaren in the following countries:
- Argentina
- Chile
- Czech Republic
- Germany
- Italy
- Malaysia
- Mexico
- Sweden
- Turkey
Diclofenac hydroxyethylpyrrolidine (a derivative of Diclofenac) is reported as an ingredient of Voltaren in the following countries:
- Germany
Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Voltaren in the following countries:
- Germany
- Slovakia
Diclofenac resinate (a derivative of Diclofenac) is reported as an ingredient of Voltaren in the following countries:
- Germany
- Switzerland
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Voltaren in the following countries:
- Algeria
- Argentina
- Australia
- Austria
- Belgium
- Benin
- Brazil
- Burkina Faso
- Cameroon
- Canada
- Central African Republic
- Chad
- Chile
- Colombia
- Congo
- Cote D'ivoire
- Croatia (Hrvatska)
- Czech Republic
- Denmark
- Ecuador
- Estonia
- Ethiopia
- Finland
- Gabon
- Georgia
- Germany
- Greece
- Guinea
- Hong Kong
- Hungary
- Iceland
- Indonesia
- Israel
- Italy
- Japan
- Latvia
- Lithuania
- Luxembourg
- Madagascar
- Malaysia
- Mali
- Malta
- Mauritania
- Mauritius
- Mexico
- Netherlands
- New Zealand
- Niger
- Norway
- Oman
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russian Federation
- Senegal
- Serbia
- Singapore
- Slovakia
- South Africa
- Spain
- Sri Lanka
- Sweden
- Switzerland
- Taiwan
- Thailand
- Togo
- Turkey
- United States
- Venezuela
- Vietnam
- Zaire
International Drug Name Search
Tuesday, October 25, 2016
Z-Histamine
Z-Histamine may be available in the countries listed below.
Ingredient matches for Z-Histamine
Chlorphenamine
Chlorphenamine is reported as an ingredient of Z-Histamine in the following countries:
- Bangladesh
International Drug Name Search
Zyflo CR
See also: Generic Zyflo
Zyflo CR is a brand name of zileuton, approved by the FDA in the following formulation(s):
ZYFLO CR (zileuton - tablet, extended release; oral)
Manufacturer: CORNERSTONE THERAP
Approval date: May 30, 2007
Strength(s): 600MG [RLD]
Has a generic version of Zyflo CR been approved?
No. There is currently no therapeutically equivalent version of Zyflo CR available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zyflo CR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Tablets with controlled-rate release of active substances
Patent 5,422,123
Issued: June 6, 1995
Inventor(s): Conte; Ubaldo & La Manna; Aldo & Colombo; Paolo
Assignee(s): Jagotec AG
Tablets with zero order controlled-rate of release of the active substances, consisting of a core of defined geometrical form containing the active substance, polymer substances which swell on contact with aqueous liquids and polymer substances with gelling properties, and a support applied to said core to partly cover its surface, the support consisting of polymer substances which are slowly soluble and/or slowly gellable in aqueous liquids, plasticizing substances, and possibly substances with an adjuvant function.Patent expiration dates:
- June 6, 2012✓
- June 6, 2012
Pharmaceutical tablet capable of liberating one or more drugs at different release rates
Patent 6,183,778
Issued: February 6, 2001
Inventor(s): Conte; Ubaldo & LaManna; Aldo & Maggi; Lauretta
Assignee(s): Jagotec AG
Pharmaceutical tablet consisting of a first layer containing one or more drugs with immediate or controlled release formulation, a second layer containing one or more drugs, either equal to or different from the first layer, with slow release formulation, and a low-permeability barrier-type layer coating said second layer or, alternatively, placed between the first and second layer and, if necessary, containing a drug.Patent expiration dates:
- September 21, 2013✓
- September 21, 2013
See also...
- Zyflo CR Extended-Release Tablets Consumer Information (Wolters Kluwer)
- Zyflo CR Consumer Information (Cerner Multum)
- Zyflo CR Advanced Consumer Information (Micromedex)
- Zileuton Consumer Information (Wolters Kluwer)
- Zileuton Extended-Release Tablets Consumer Information (Wolters Kluwer)
- Zileuton Consumer Information (Cerner Multum)
- Zileuton Advanced Consumer Information (Micromedex)
- Zileuton AHFS DI Monographs (ASHP)
Sure LD
Sure LD may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Sure LD
Levamisole
Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Sure LD in the following countries:
- United Kingdom
International Drug Name Search
Glomerulonephritis Medications
Definition of Glomerulonephritis: Glomerulonephritis is a type of kidney disease caused by inflammation of the internal kidney structures (glomeruli).
Drugs (by generic name) associated with Glomerulonephritis
The following drugs and medications are in some way related to, or used in the treatment of Glomerulonephritis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Topics under Glomerulonephritis
- IgA Nephropathy (3 drugs)
Learn more about Glomerulonephritis
Medical Encyclopedia:
- Glomerulonephritis
Harvard Health Guide:
- Symptoms and treatment for Glomerulonephritis
Drug List:
Monday, October 24, 2016
Vitamine D3 BON
Vitamine D3 BON may be available in the countries listed below.
Ingredient matches for Vitamine D3 BON
Colecalciferol
Colecalciferol is reported as an ingredient of Vitamine D3 BON in the following countries:
- Algeria
- France
- Lithuania
- Sri Lanka
- Tunisia
- Vietnam
International Drug Name Search
Malaria Medications
Definition of Malaria: A parasitic disease characterized by fever, chills, and anemia.
Drugs associated with Malaria
The following drugs and medications are in some way related to, or used in the treatment of Malaria. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
See sub-topics
Topics under Malaria
- Malaria Prevention (16 drugs)
Learn more about Malaria
Medical Encyclopedia:
- Malaria
Harvard Health Guide:
- Symptoms and treatment for Malaria
Drug List:
Nikofrenon
Nikofrenon may be available in the countries listed below.
Ingredient matches for Nikofrenon
Nicotine
Nicotine is reported as an ingredient of Nikofrenon in the following countries:
- Germany
International Drug Name Search
Somazina
Somazina may be available in the countries listed below.
Ingredient matches for Somazina
Citicoline
Citicoline is reported as an ingredient of Somazina in the following countries:
- Brazil
- Bulgaria
- Chile
- Costa Rica
- Dominican Republic
- Ecuador
- El Salvador
- Georgia
- Guatemala
- Honduras
- Nicaragua
- Panama
- Peru
- Portugal
- Spain
- Venezuela
- Vietnam
Citicoline sodium salt (a derivative of Citicoline) is reported as an ingredient of Somazina in the following countries:
- Argentina
- Brazil
- Chile
- Colombia
- Malta
- Mexico
International Drug Name Search
Nadiflo
Nadiflo may be available in the countries listed below.
Ingredient matches for Nadiflo
Nadifloxacin
Nadifloxacin is reported as an ingredient of Nadiflo in the following countries:
- Japan
International Drug Name Search
Neoformin
Neoformin may be available in the countries listed below.
Ingredient matches for Neoformin
Metformin
Metformin is reported as an ingredient of Neoformin in the following countries:
- Bulgaria
International Drug Name Search
Sevorane
Sevorane may be available in the countries listed below.
Ingredient matches for Sevorane
Sevoflurane
Sevoflurane is reported as an ingredient of Sevorane in the following countries:
- Argentina
- Australia
- Austria
- Belgium
- Bosnia & Herzegowina
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Costa Rica
- Croatia (Hrvatska)
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Guatemala
- Honduras
- Hong Kong
- Hungary
- Iceland
- Indonesia
- Israel
- Italy
- Latvia
- Lithuania
- Luxembourg
- Mexico
- New Zealand
- Nicaragua
- Norway
- Panama
- Peru
- Philippines
- Poland
- Romania
- Serbia
- Singapore
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Thailand
- Tunisia
- Turkey
- Venezuela
International Drug Name Search
Oralject Sedazine ACP
Oralject Sedazine ACP may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Oralject Sedazine ACP
Acepromazine
Acepromazine maleate (a derivative of Acepromazine) is reported as an ingredient of Oralject Sedazine ACP in the following countries:
- New Zealand
International Drug Name Search
Zopiclon von CT
Zopiclon von CT may be available in the countries listed below.
Ingredient matches for Zopiclon von CT
Eszopiclone
Zopiclone is reported as an ingredient of Zopiclon von CT in the following countries:
- Germany
International Drug Name Search
Sunday, October 23, 2016
Nife von ct
nife von ct may be available in the countries listed below.
Ingredient matches for nife von ct
Nifedipine
Nifedipine is reported as an ingredient of nife von ct in the following countries:
- Romania
International Drug Name Search
Dothep
Dothep may be available in the countries listed below.
Ingredient matches for Dothep
Dosulepin
Dosulepin hydrochloride (a derivative of Dosulepin) is reported as an ingredient of Dothep in the following countries:
- Australia
- Ireland
International Drug Name Search
Nevirapine Stada
Nevirapine Stada may be available in the countries listed below.
Ingredient matches for Nevirapine Stada
Nevirapine
Nevirapine is reported as an ingredient of Nevirapine Stada in the following countries:
- Vietnam
International Drug Name Search
Dermacom
Dermacom may be available in the countries listed below.
Ingredient matches for Dermacom
Butenafine
Butenafine hydrochloride (a derivative of Butenafine) is reported as an ingredient of Dermacom in the following countries:
- Chile
International Drug Name Search
Superspray
Superspray may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Superspray
Chlorhexidine
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Superspray in the following countries:
- United Kingdom
International Drug Name Search
D-Lactate
D-Lactate may be available in the countries listed below.
Ingredient matches for D-Lactate
Calcium Lactate
Calcium Lactate is reported as an ingredient of D-Lactate in the following countries:
- Bangladesh
International Drug Name Search
Diclotard
Diclotard may be available in the countries listed below.
Ingredient matches for Diclotard
Diclofenac
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclotard in the following countries:
- Poland
- Romania
International Drug Name Search
Deflazacort
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
H02AB13
CAS registry number (Chemical Abstracts Service)
0014484-47-0
Chemical Formula
C25-H31-N-O6
Molecular Weight
441
Therapeutic Category
Adrenal cortex hormone, glucocorticoid
Chemical Name
5'H-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione, 21-(acetyloxy)-11-hydroxy-2'-methyl-, (11ß,16ß)-
Foreign Names
- Deflazacortum (Latin)
- Deflazacort (German)
- Déflazacort (French)
- Deflazacort (Spanish)
Generic Names
- Deflazacort (OS: BAN, DCIT, USAN)
- Déflazacort (OS: DCF)
- Azacort (IS)
- DL 458-IT (IS)
- L 5458 (IS)
- MDL 458 (IS)
- Oxacort (IS)
Brand Names
- Aflazacort
ABL, Peru - Azacortid
Sanofi-Aventis, Argentina; Sanofi-Aventis, Chile - Calcort
Aventis, Luxembourg; Galenpharma, Germany; Sanofi Aventis, Antigua & Barbuda; Sanofi Aventis, Netherlands Antilles; Sanofi Aventis, Aruba; Sanofi Aventis, Barbados; Sanofi Aventis, Bermuda; Sanofi Aventis, Bahamas; Sanofi Aventis, Guyana; Sanofi Aventis, Haiti; Sanofi Aventis, Haiti; Sanofi Aventis, Jamaica; Sanofi Aventis, Cayman Islands; Sanofi Aventis, Saint Lucia; Sanofi Aventis, Trinidad & Tobago; Sanofi Aventis, Saint Vincent & The Grenadines; Sanofi-Aventis, Brazil; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Dominican Republic; Sanofi-Aventis, Ecuador; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Guatemala; Sanofi-Aventis, Honduras; Sanofi-Aventis, Mexico; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Panama; Sanofi-Aventis, Peru; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Venezuela - Clobak
Incobra, Colombia; Incobra, Peru - Defas
Rontag, Argentina - Deflacort
Galeno, Colombia; Galeno, Peru - Deflan
Guidotti, Italy; IFET, Greece - Deflanil
Libbs, Brazil - Deflax
Gotland, Colombia - Deflazacort Alter
Alter, Spain - Deflazacort Cantabria
Cantabria, Spain - Deflazacort MK
MK, Colombia - Deflazacort Sandoz
Sandoz, Spain - Deflazacort Stada
Stada, Spain - Deflazacort
Dosa, Argentina; Farmindustria, Peru; Genéricos Venezolanos, Venezuela; Rowa, Peru - Denacen
Marjan, Brazil - Dezacor
Faes, Spain - Dezartal
Andromaco, Chile - Farmacortix
Farmindustria, Peru - Flacort
AC Farma, Peru - Flamirex
Sanofi-Aventis, Argentina - Flantadin
Sanofi-Aventis, Turkey; Teofarma, Italy - Lantadin
Sanofi-Aventis, Colombia - Rosilan
Vitoria, Portugal - Setatrep
Lemery, Mexico - Solme
Blubell, India - Zamene
Menarini, Spain
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Oxytetracycline Hydrochloride
Ingredient matches for Oxytetracycline Hydrochloride
Oxytetracycline
Oxytetracycline Hydrochloride (BANM, JAN) is known as Oxytetracycline in the US.
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| JAN | Japanese Accepted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Serlo
Serlo may be available in the countries listed below.
Ingredient matches for Serlo
Sertraline
Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Serlo in the following countries:
- Ireland
International Drug Name Search
Glanders Medications
Definition of Glanders: A highly contagious and very destructive disease of horses, asses, mules, etc, characterised by a constant discharge of sticky matter from the nose, and an enlargement and induration of the glands beneath and within the lower jaw. It may transmitted to dogs, goats, sheep, and to human beings. Source: Websters Dictionary
Drugs associated with Glanders
The following drugs and medications are in some way related to, or used in the treatment of Glanders. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug List:
Slow-Lopresor
Slow-Lopresor may be available in the countries listed below.
Ingredient matches for Slow-Lopresor
Metoprolol
Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of Slow-Lopresor in the following countries:
- Luxembourg
International Drug Name Search
Sulka S
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Sulka S
Sulfadimidine
Sulfadimidine is reported as an ingredient of Sulka S in the following countries:
- United States
International Drug Name Search
Celexa
Celexa is a brand name of citalopram, approved by the FDA in the following formulation(s):
CELEXA (citalopram hydrobromide - solution; oral)
Manufacturer: FOREST LABS
Approval date: December 22, 1999
Strength(s): EQ 10MG BASE/5ML [RLD][AA]
CELEXA (citalopram hydrobromide - tablet; oral)
Manufacturer: FOREST LABS
Approval date: July 17, 1998
Strength(s): EQ 20MG BASE [AB], EQ 40MG BASE [RLD][AB]
Manufacturer: FOREST LABS
Approval date: April 27, 2000
Strength(s): EQ 10MG BASE [AB]
Has a generic version of Celexa been approved?
Yes. The following products are equivalent to Celexa:
citalopram hydrobromide solution; oral
Manufacturer: AUROBINDO PHARMA LTD
Approval date: August 28, 2006
Strength(s): EQ 10MG BASE/5ML [AA]
Manufacturer: ROXANE
Approval date: December 13, 2004
Strength(s): EQ 10MG BASE/5ML [AA]
Manufacturer: SILARX
Approval date: June 15, 2006
Strength(s): EQ 10MG BASE/5ML [AA]
citalopram hydrobromide tablet; oral
Manufacturer: ALPHAPHARM
Approval date: November 5, 2004
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: AMNEAL PHARMS NY
Approval date: November 30, 2006
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: APOTEX INC
Approval date: November 24, 2004
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: AUROBINDO
Approval date: October 28, 2004
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: CARACO
Approval date: November 12, 2004
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: COREPHARMA
Approval date: October 28, 2004
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: DR REDDYS LABS LTD
Approval date: October 28, 2004
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: EPIC PHARMA
Approval date: April 29, 2005
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: GLENMARK GENERICS
Approval date: February 27, 2009
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: INVAGEN PHARMS
Approval date: October 3, 2006
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: IVAX SUB TEVA PHARMS
Approval date: November 16, 2004
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: MYLAN
Approval date: November 5, 2004
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: MYLAN
Approval date: February 3, 2005
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: NATCO PHARMA LTD
Approval date: April 10, 2008
Strength(s): EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: PLIVA
Approval date: October 31, 2005
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: SANDOZ
Approval date: October 28, 2004
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: TORRENT PHARMS
Approval date: March 27, 2007
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: WATSON LABS
Approval date: November 5, 2004
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Manufacturer: WATSON LABS
Approval date: June 30, 2005
Strength(s): EQ 10MG BASE [AB], EQ 20MG BASE [AB], EQ 40MG BASE [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Celexa. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Celexa.
See also...
- Celexa Consumer Information (Drugs.com)
- Celexa Consumer Information (Wolters Kluwer)
- Celexa Solution Consumer Information (Wolters Kluwer)
- Celexa Consumer Information (Cerner Multum)
- Celexa Advanced Consumer Information (Micromedex)
- Celexa AHFS DI Monographs (ASHP)
- Citalopram Consumer Information (Drugs.com)
- Citalopram Consumer Information (Wolters Kluwer)
- Citalopram Solution Consumer Information (Wolters Kluwer)
- Citalopram Consumer Information (Cerner Multum)
- Citalopram Advanced Consumer Information (Micromedex)
- Citalopram Hydrobromide AHFS DI Monographs (ASHP)
Saturday, October 22, 2016
Depotocin
Depotocin may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Depotocin
Carbetocin
Carbetocin is reported as an ingredient of Depotocin in the following countries:
- Germany
International Drug Name Search
Hemolisat
Hemolisat may be available in the countries listed below.
Ingredient matches for Hemolisat
Lidocaine
Lidocaine is reported as an ingredient of Hemolisat in the following countries:
- Japan
Tribenoside
Tribenoside is reported as an ingredient of Hemolisat in the following countries:
- Japan
International Drug Name Search
Omacip
Omacip may be available in the countries listed below.
Ingredient matches for Omacip
Ciprofloxacin
Ciprofloxacin is reported as an ingredient of Omacip in the following countries:
- Oman
International Drug Name Search
Difenilpiralina
Difenilpiralina may be available in the countries listed below.
Ingredient matches for Difenilpiralina
Diphenylpyraline
Difenilpiralina (DCIT) is also known as Diphenylpyraline (Rec.INN)
International Drug Name Search
Glossary
| DCIT | Denominazione Comune Italiana |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Oftulix
Oftulix may be available in the countries listed below.
Ingredient matches for Oftulix
Diclofenac
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Oftulix in the following countries:
- Colombia
International Drug Name Search
Friday, October 21, 2016
Orfiril
Orfiril may be available in the countries listed below.
Ingredient matches for Orfiril
Valproic Acid
Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Orfiril in the following countries:
- Czech Republic
- Denmark
- Estonia
- Finland
- Germany
- Hungary
- Iceland
- Israel
- Netherlands
- Norway
- Peru
- Poland
- Romania
- Singapore
- Slovakia
- Sweden
- Switzerland
International Drug Name Search
Staphen
Staphen may be available in the countries listed below.
Ingredient matches for Staphen
Flucloxacillin
Flucloxacillin sodium salt (a derivative of Flucloxacillin) is reported as an ingredient of Staphen in the following countries:
- Bangladesh
International Drug Name Search
Hydrofluoric Acid
Hydrofluoric Acid may be available in the countries listed below.
Ingredient matches for Hydrofluoric Acid
Calcium Gluconate
Calcium Gluconate is reported as an ingredient of Hydrofluoric Acid in the following countries:
- Singapore
International Drug Name Search
Orbenin
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Orbenin
Cloxacillin
Cloxacillin is reported as an ingredient of Orbenin in the following countries:
- Bahrain
- Bosnia & Herzegowina
- Guyana
- Iran
- Kuwait
- Luxembourg
- New Zealand
- Oman
- Qatar
- Slovenia
- Thailand
- United Arab Emirates
Cloxacillin benzathine (a derivative of Cloxacillin) is reported as an ingredient of Orbenin in the following countries:
- Australia
- Austria
- Finland
- France
- Germany
- Italy
- New Zealand
- Portugal
- South Africa
- United Kingdom
- United States
Cloxacillin sodium salt (a derivative of Cloxacillin) is reported as an ingredient of Orbenin in the following countries:
- Belgium
- Croatia (Hrvatska)
- Ethiopia
- France
- Greece
- Luxembourg
- New Zealand
- Philippines
- Spain
- United Kingdom
International Drug Name Search
Doxazosina EG
Doxazosina EG may be available in the countries listed below.
Ingredient matches for Doxazosina EG
Doxazosin
Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Doxazosina EG in the following countries:
- Italy
International Drug Name Search
Cystic Fibrosis with Ileus Medications
There are currently no drugs listed for "Cystic Fibrosis with Ileus".
Learn more about Cystic Fibrosis with Ileus
Micromedex Care Notes:
- Cystic Fibrosis
- Cystic Fibrosis In Children
Medical Encyclopedia:
- Cystic fibrosis
Drug List:
Thursday, October 20, 2016
Dacriosol
Dacriosol may be available in the countries listed below.
Ingredient matches for Dacriosol
Dextran
Dextran is reported as an ingredient of Dacriosol in the following countries:
- Italy
Dextran average molecular weight about 70000 (a derivative of Dextran) is reported as an ingredient of Dacriosol in the following countries:
- Denmark
Hypromellose
Hypromellose is reported as an ingredient of Dacriosol in the following countries:
- Denmark
- Italy
International Drug Name Search
Antihyperlipidemic agents
Antihyperlipidemic agents promote reduction of lipid levels in the blood. Some antihyperlipidemic agents aim to lower the levels of low-density lipoprotein (LDL) cholesterol, some reduce triglyceride levels, and some help raise the high-density lipoprotein (HDL) cholesterol. By reducing the LDL cholesterol, they can prevent both the primary and secondary symptoms of coronary heart disease.
See also
- antihyperlipidemic combinations
- bile acid sequestrants
- cholesterol absorption inhibitors
- fibric acid derivatives
- miscellaneous antihyperlipidemic agents
- statins
Drug List:
Deep Vein Thrombosis, Recurrent Event Medications
Drugs associated with Deep Vein Thrombosis, Recurrent Event
The following drugs and medications are in some way related to, or used in the treatment of Deep Vein Thrombosis, Recurrent Event. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Learn more about Deep Vein Thrombosis, Recurrent Event
Micromedex Care Notes:
- Deep Venous Thrombosis
Medical Encyclopedia:
- Deep venous thrombosis
Drug List:
Wormout
Wormout may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Wormout
Oxfendazole
Oxfendazole is reported as an ingredient of Wormout in the following countries:
- Australia
Praziquantel
Praziquantel is reported as an ingredient of Wormout in the following countries:
- Australia
International Drug Name Search
Cauda Equina Syndrome w/ Neurogenic Bladder Medications
There are currently no drugs listed for "Cauda Equina Syndrome w/ Neurogenic Bladder".
Learn more about Cauda Equina Syndrome w/ Neurogenic Bladder
Micromedex Care Notes:
- Sexual Function In Men After Spinal Cord Injury
- Sexual Function In Women After Spinal Cord Injury
Medical Encyclopedia:
- Spinal cord trauma
Drug List:
Oxarol
Oxarol may be available in the countries listed below.
Ingredient matches for Oxarol
Maxacalcitol
Maxacalcitol is reported as an ingredient of Oxarol in the following countries:
- Japan
International Drug Name Search
Orgamox
Orgamox may be available in the countries listed below.
Ingredient matches for Orgamox
Amoxicillin
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Orgamox in the following countries:
- Bangladesh
International Drug Name Search
Hepronicate
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0007237-81-2
Chemical Formula
C28-H31-N3-O6
Molecular Weight
505
Therapeutic Category
Vasodilator, peripheric
Chemical Name
3-Pyridinecarboxylic acid, 2-hexyl-2-[[(3-pyridinylcarbonyl)oxy]methyl]-1,3-propanediyl ester
Foreign Names
- Hepronicatum (Latin)
- Hepronicat (German)
- Hépronicate (French)
- Hepronicato (Spanish)
Generic Names
- Hepronicate (OS: JAN)
- CLY 115 (IS)
- Heptylidintrimethyl trinicotinat (IS)
Brand Name
- Megrin
Choseido Pharmaceutical, Japan
International Drug Name Search
Glossary
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Wednesday, October 19, 2016
Orapred
In the US, Orapred (prednisolone systemic) is a member of the drug class glucocorticoids and is used to treat Asthma - acute, Bullous Pemphigoid, Dermatitis, Immunosuppression, Inflammatory Conditions, Multiple Sclerosis, Nephrotic Syndrome, Pemphigoid and Pemphigus.
US matches:
- Orapred
- Orapred ODT
- Orapred Solution
Ingredient matches for Orapred
Prednisolone
Prednisolone 21-(disodium phosphate) (a derivative of Prednisolone) is reported as an ingredient of Orapred in the following countries:
- United States
International Drug Name Search
Lamisil
Lamisil is a brand name of terbinafine, approved by the FDA in the following formulation(s):
LAMISIL (terbinafine hydrochloride - granule; oral)
Manufacturer: NOVARTIS
Approval date: September 28, 2007
Strength(s): EQ 125MG BASE/PACKET, EQ 187.5MG BASE/PACKET [RLD]
LAMISIL (terbinafine hydrochloride - tablet; oral)
Manufacturer: NOVARTIS
Approval date: May 10, 1996
Strength(s): EQ 250MG BASE [RLD][AB]
Has a generic version of Lamisil been approved?
Yes. The following products are equivalent to Lamisil:
terbinafine hydrochloride tablet; oral
Manufacturer: APOTEX
Approval date: July 2, 2007
Strength(s): EQ 250MG BASE [AB]
Manufacturer: AUROBINDO PHARMA
Approval date: July 2, 2007
Strength(s): EQ 250MG BASE [AB]
Manufacturer: BRECKENRIDGE PHARM
Approval date: June 4, 2010
Strength(s): EQ 250MG BASE [AB]
Manufacturer: DR REDDYS LABS INC
Approval date: July 2, 2007
Strength(s): EQ 250MG BASE [AB]
Manufacturer: GLENMARK GENERICS
Approval date: July 2, 2007
Strength(s): EQ 250MG BASE [AB]
Manufacturer: HARRIS PHARM
Approval date: July 2, 2007
Strength(s): EQ 250MG BASE [AB]
Manufacturer: INVAGEN PHARMS
Approval date: July 2, 2007
Strength(s): EQ 250MG BASE [AB]
Manufacturer: MYLAN
Approval date: July 2, 2007
Strength(s): EQ 250MG BASE [AB], EQ 250MG BASE [AB]
Manufacturer: ORCHID HLTHCARE
Approval date: July 2, 2007
Strength(s): EQ 250MG BASE [AB]
Manufacturer: TEVA
Approval date: July 2, 2007
Strength(s): EQ 250MG BASE [AB]
Manufacturer: WATSON LABS
Approval date: July 2, 2007
Strength(s): EQ 250MG BASE [AB]
Manufacturer: WOCKHARDT
Approval date: July 2, 2007
Strength(s): EQ 250MG BASE [AB]
Note: No generic formulation of the following product is available.
- terbinafine hydrochloride - granule; oral
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lamisil. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Lamisil.
See also...
- Lamisil Consumer Information (Drugs.com)
- Lamisil Consumer Information (Wolters Kluwer)
- Lamisil Oral Granules Consumer Information (Wolters Kluwer)
- Lamisil Consumer Information (Cerner Multum)
- Lamisil Advanced Consumer Information (Micromedex)
- Lamisil AHFS DI Monographs (ASHP)
- Terbinafine Consumer Information (Wolters Kluwer)
- Terbinafine Granules Consumer Information (Wolters Kluwer)
- Terbinafine Consumer Information (Cerner Multum)
- Terbinex Advanced Consumer Information (Micromedex)
- Terbinafine Advanced Consumer Information (Micromedex)
- Terbinafine Hydrochloride AHFS DI Monographs (ASHP)
Startonyl
Startonyl may be available in the countries listed below.
Ingredient matches for Startonyl
Citicoline
Citicoline is reported as an ingredient of Startonyl in the following countries:
- Austria
Citicoline sodium salt (a derivative of Citicoline) is reported as an ingredient of Startonyl in the following countries:
- Portugal
International Drug Name Search
Supositorios Glicerina Viviar
Supositorios Glicerina Viviar may be available in the countries listed below.
Ingredient matches for Supositorios Glicerina Viviar
Glycerol
Glycerol is reported as an ingredient of Supositorios Glicerina Viviar in the following countries:
- Spain
International Drug Name Search
Dicloxacillin
In some countries, this medicine may only be approved for veterinary use.
In the US, Dicloxacillin (dicloxacillin systemic) is a member of the drug class penicillinase resistant penicillins and is used to treat Bone infection, Bronchitis, Pharyngitis, Pneumonia, Skin Infection and Upper Respiratory Tract Infection.
US matches:
- Dicloxacillin
- Dicloxacillin Sodium
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J01CF01
CAS registry number (Chemical Abstracts Service)
0003116-76-5
Chemical Formula
C19-H17-Cl2-N3-O5-S
Molecular Weight
470
Therapeutic Category
Antibacterial: Penicillin, penicillinase-resistant
Chemical Name
6-[3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Foreign Names
- Dicloxacillinum (Latin)
- Dicloxacillin (German)
- Dicloxacilline (French)
- Dicloxacilina (Spanish)
Generic Names
- Dicloxacillin (OS: BAN, USAN)
- Dicloxacillina (OS: DCIT)
- Dicloxacilline (OS: DCF)
- Bayer 5488 (IS: Bayer)
- BRL 1702 (IS)
- R 13423 (IS)
- Dicloxacillin Sodium (OS: USAN, BANM)
- P 1011 (IS)
- Dicloxacillin Sodium (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XIV)
- Dicloxacillin Sodium Hydrate (PH: JP XV)
- Dicloxacilline sodique (PH: Ph. Eur. 6)
- Dicloxacillin-Natrium (PH: Ph. Eur. 6)
- Dicloxacillinum natricum (PH: Ph. Int. 4, Ph. Eur. 6)
Brand Names
- Clynox (Dicloxacillin and Amoxicillin)
Micro Eros, India - Damacir
Weider, Colombia - Dicloxacilina Genfar
Genfar, Colombia; Genfar, Ecuador; Genfar, Peru - Dicloxacilina La Santé
La Santé, Colombia - Dicloxacilina MF
Marfan, Peru - Dicloxacilina MK
McKesson, Ecuador; MK, Colombia - Dicloxacilina Perugen
Perugen, Peru - Dicloxacilina
AC Farma, Peru; American Generics, Peru; AZ Pharma, Colombia; Blaskov, Colombia; Britania, Peru; Farmindustria, Peru; Farmo Andina, Peru; Hersil, Peru; Infarmasa, Peru; Iqfarma, Peru; La Sante, Peru; LCG, Peru; Medicalex, Colombia; Medick, Colombia; Medifarma, Peru; Pentacoop, Colombia; Pentacoop, Peru; Salufarma, Peru; Synthesis, Colombia; Tranfarma, Peru; Trifarma, Peru; UQP, Peru - Dicloxina
ECU, Ecuador; Iqfarma, Peru - Dyclobiot
Trifarma, Peru - Lexmox-DC (Dicloxacillin and Amoxicillin)
Lexus, India - Lomox-D (Dicloxacillin and Amoxicillin)
Cubit, India - Moxtid-D (Dicloxacillin and Amoxicillin)
Allenge, India - O-Moxy-DC (Dicloxacillin and Amoxicillin)
Zubit, India - Terbocloxil
Terbol, Peru - Zamoxy-D (Dicloxacillin and Amoxicillin)
Zodak, India - Betaclox
Eskayef, Bangladesh - Brispen
Hormona, Mexico - Butimaxil
Bruluagsa, Mexico - Cloxagen
Genamerica, Ecuador - Combipenix (Dicloxacillin and Ampicillin)
Asahi Kasei, Japan - Dacocilin
CCPC, Taiwan - Diamsalina
Antibioticos, Mexico - Dicillin
Sandoz, Denmark - Diclex
Meiji, Thailand - Diclocil
Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Peru; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Venezuela - Diclocin
Synpac, Taiwan - Diclomax
Markos, Peru - Dicloxacillin Sodium
Sandoz, United States; Teva USA, United States - Dicloxal
Magma, Peru - Dicloxin (veterinary use)
Fort Dodge Animale Health, United States - Dicloxsig
Sigma, Australia - Dikloxacillin Meda
Meda, Sweden - Dimotic (Dicloxacillin and Amoxicillin)
Candor, India - Distaph
Alphapharm, Australia - Ditterolina
Ivax, Mexico - H.G. Dicloxacil
H.G., Ecuador - InfectoStaph
Infectopharm, Germany - Posipen
GlaxoSmithKline, Peru; Sanfer, Mexico - Staklos
Actavis, Iceland
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Tri-Luma
Tri-Luma is a brand name of fluocinolone/hydroquinone/tretinoin topical, approved by the FDA in the following formulation(s):
TRI-LUMA (fluocinolone acetonide; hydroquinone; tretinoin - cream; topical)
Manufacturer: GALDERMA LABS LP
Approval date: January 18, 2002
Strength(s): 0.01%;4%;0.05% [RLD]
Has a generic version of Tri-Luma been approved?
No. There is currently no therapeutically equivalent version of Tri-Luma available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tri-Luma. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Topical skin care composition
Patent 7,915,243
Issued: March 29, 2011
Inventor(s): Puglia; Nancy & Ramirez; Rosario & Roth; Jerry
Assignee(s): Galderma S.A.
A cream base for the topical application of skin care therapeutics and a process for making the cream base. In one embodiment, the therapeutic is tretinoin, hydroquinone and fluocinolone acetonide for the treatment of hyperpigmented skin conditions, such as melasma.Patent expiration dates:
- March 22, 2026✓
- March 22, 2026
Topical skin care composition
Patent 7,939,516
Issued: May 10, 2011
Inventor(s): Puglia; Nancy & Roth; Jerry & Ramirez; Rosario
Assignee(s): Galderma S.A.
A cream base for the topical application of skin care therapeutics and a process for making the cream base. In one embodiment, the therapeutic is tretinoin, hydroquinone and fluocinolone acetonide for the treatment of hyperpigmented skin conditions, such as melasma.Patent expiration dates:
- May 4, 2025✓
- May 4, 2025
See also...
- Tri-Luma Consumer Information (Wolters Kluwer)
- Tri-Luma Consumer Information (Cerner Multum)
- Fluocinolone/Hydroquinone/Tretinoin Consumer Information (Wolters Kluwer)
- Fluocinolone, hydroquinone, and tretinoin topical Consumer Information (Cerner Multum)
Tazorac
Tazorac is a brand name of tazarotene topical, approved by the FDA in the following formulation(s):
TAZORAC (tazarotene - cream; topical)
Manufacturer: ALLERGAN
Approval date: September 29, 2000
Strength(s): 0.05% [RLD], 0.1% [RLD]
TAZORAC (tazarotene - gel; topical)
Manufacturer: ALLERGAN
Approval date: June 13, 1997
Strength(s): 0.05% [RLD], 0.1% [RLD]
Has a generic version of Tazorac been approved?
No. There is currently no therapeutically equivalent version of Tazorac available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tazorac. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Stable gel formulation for topical treatment of skin conditions
Patent 5,914,334
Issued: June 22, 1999
Inventor(s): Charu; Prakash M.
Assignee(s): Allergan, Inc.
The present invention provides a stable gel formulation for topical treatment of skin conditions in humans. The stable gel formulation includes an active agent, having activity for treatment of acne and psoriasis, which is insoluble in water and a plurality of nonaqueous vehicles for both solubilizing said active agent and forming a gel therewith enabling topical application of the gel to a skin condition. The plurality of vehicles are each present in amounts, and in combination, to control release of the active agent from the gel to the skin condition.Patent expiration dates:
- June 7, 2014✓
- June 7, 2014
Stable gel formulation for topical treatment of skin conditions
Patent 6,258,830
Issued: July 10, 2001
Inventor(s): Charu; Prakash M.
Assignee(s): Allergan Sales, Inc.
The present invention provides a stable gel formulation for topical treatment of skin conditions in humans. The stable gel formulation includes an active agent, having activity for treatment of acne and psoriasis, which is insoluble in water and a plurality of nonaqueous vehicles for both solubilizing said active agent and forming a gel therewith enabling topical application of the gel to a skin condition. The plurality of vehicles are each present in amounts, and in combination, to control release of the active agent from-the gel to the skin condition.Patent expiration dates:
- June 7, 2014✓
- June 7, 2014
See also...
- Tazorac Cream Consumer Information (Wolters Kluwer)
- Tazorac Gel Consumer Information (Wolters Kluwer)
- Tazorac Consumer Information (Cerner Multum)
- Tazorac Topical Advanced Consumer Information (Micromedex)
- Tazarotene Cream Consumer Information (Wolters Kluwer)
- Tazarotene Gel Consumer Information (Wolters Kluwer)
- Tazarotene topical Consumer Information (Cerner Multum)
- Tazarotene Topical Advanced Consumer Information (Micromedex)
- Tazarotene AHFS DI Monographs (ASHP)
Subscribe to:
Posts (Atom)